BACKGROUND AND PURPOSE: The purpose of this study was to investigate the relationship between cerebrovascular autoregulation and outcome after aneurysmal subarachnoid hemorrhage. METHODS: In a prospective observational study, 80 patients after severe subarachnoid hemorrhage were continuously monitored for cerebral perfusion pressure and partial pressure of brain tissue oxygen for an average of 7.9 days (range, 1.9-14.9 days). Autoregulation was assessed using the index of brain tissue oxygen pressure reactivity (ORx), a moving correlation coefficient between cerebral perfusion pressure and partial pressure of brain tissue oxygen. High ORx indicates impaired autoregulation; low ORx signifies intact autoregulation. Outcome was determined at 6 months and dichotomized into favorable (Glasgow Outcome Scale 4-5) and unfavorable outcome (Glasgow Outcome Scale 1-3). RESULTS: Twenty-four patients had a favorable and 56 an unfavorable outcome. In a univariate analysis, there were significant differences in autoregulation (ORx 0.19±0.10 versus 0.37±0.11, P<0.001, for favorable versus unfavorable outcome, respectively), age (44.1±11.0 years versus 54.2±12.1 years, P=0.001), occurrence of delayed cerebral infarction (8% versus 46%, P<0.001), use of coiling (25% versus 54%, P=0.02), partial pressure of brain tissue oxygen (24.9±6.6 mm Hg versus 21.8±6.3 mm Hg, P=0.048), and Fisher grade (P=0.03). In a multivariate analysis, ORx (P<0.001) and age (P=0.003) retained an independent predictive value for outcome. ORx correlated with Glasgow Outcome Scale (r=-0.70, P<0.001). CONCLUSIONS: The status of cerebrovascular autoregulation might be an important pathophysiological factor in the disease process after subarachnoid hemorrhage, because impaired autoregulation was independently associated with an unfavorable outcome.
BACKGROUND AND PURPOSE: The purpose of this study was to investigate the relationship between cerebrovascular autoregulation and outcome after aneurysmal subarachnoid hemorrhage. METHODS: In a prospective observational study, 80 patients after severe subarachnoid hemorrhage were continuously monitored for cerebral perfusion pressure and partial pressure of brain tissue oxygen for an average of 7.9 days (range, 1.9-14.9 days). Autoregulation was assessed using the index of brain tissue oxygen pressure reactivity (ORx), a moving correlation coefficient between cerebral perfusion pressure and partial pressure of brain tissue oxygen. High ORx indicates impaired autoregulation; low ORx signifies intact autoregulation. Outcome was determined at 6 months and dichotomized into favorable (Glasgow Outcome Scale 4-5) and unfavorable outcome (Glasgow Outcome Scale 1-3). RESULTS: Twenty-four patients had a favorable and 56 an unfavorable outcome. In a univariate analysis, there were significant differences in autoregulation (ORx 0.19±0.10 versus 0.37±0.11, P<0.001, for favorable versus unfavorable outcome, respectively), age (44.1±11.0 years versus 54.2±12.1 years, P=0.001), occurrence of delayed cerebral infarction (8% versus 46%, P<0.001), use of coiling (25% versus 54%, P=0.02), partial pressure of brain tissue oxygen (24.9±6.6 mm Hg versus 21.8±6.3 mm Hg, P=0.048), and Fisher grade (P=0.03). In a multivariate analysis, ORx (P<0.001) and age (P=0.003) retained an independent predictive value for outcome. ORx correlated with Glasgow Outcome Scale (r=-0.70, P<0.001). CONCLUSIONS: The status of cerebrovascular autoregulation might be an important pathophysiological factor in the disease process after subarachnoid hemorrhage, because impaired autoregulation was independently associated with an unfavorable outcome.
Authors: Jurgen A H R Claassen; Aisha S S Meel-van den Abeelen; David M Simpson; Ronney B Panerai Journal: J Cereb Blood Flow Metab Date: 2016-01-18 Impact factor: 6.200
Authors: Khalil M Yousef; Jeffrey R Balzer; Catherine M Bender; Leslie A Hoffman; Samuel M Poloyac; Feifei Ye; Paula R Sherwood Journal: J Neurosci Nurs Date: 2015-08 Impact factor: 1.230
Authors: Jasper H van Lieshout; Maxine Dibué-Adjei; Jan F Cornelius; Philipp J Slotty; Toni Schneider; Tanja Restin; Hieronymus D Boogaarts; Hans-Jakob Steiger; Athanasios K Petridis; Marcel A Kamp Journal: Neurosurg Rev Date: 2017-02-18 Impact factor: 3.042
Authors: Gabriela A Santos; Nils Petersen; Amir A Zamani; Rose Du; Sarah LaRose; Andrew Monk; Farzaneh A Sorond; Can Ozan Tan Journal: Neurology Date: 2016-04-22 Impact factor: 9.910
Authors: Paul Pham; Jessica Bindra; Anders Aneman; Alwin Chuan; John M Worthington; Matthias Jaeger Journal: Neurocrit Care Date: 2019-02 Impact factor: 3.210
Authors: Detian Wang; Ashwin B Parthasarathy; Wesley B Baker; Kimberly Gannon; Venki Kavuri; Tiffany Ko; Steven Schenkel; Zhe Li; Zeren Li; Michael T Mullen; John A Detre; Arjun G Yodh Journal: Biomed Opt Express Date: 2016-02-03 Impact factor: 3.732
Authors: Johann Fontana; Julius Moratin; Gregory Ehrlich; Johann Scharf; Christel Weiß; Kirsten Schmieder; Martin Barth Journal: Neurocrit Care Date: 2015-12 Impact factor: 3.210
Authors: Catharina Conzen; Walid Albanna; Miriam Weiss; David Kürten; Walthard Vilser; Konstantin Kotliar; Charlotte Zäske; Hans Clusmann; Gerrit Alexander Schubert Journal: Transl Stroke Res Date: 2017-11-08 Impact factor: 6.829